STANLEY MORGAN Insider Trading $CYCC Cyclacel Pharmaceuticals, Inc.
Get free email notifications about insider trading for STANLEY MORGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STANLEY MORGAN. STANLEY MORGAN is 10% Owner in BLACKROCK INVESTMENT QUALITY MUNICIPAL INCOME TRUST ($RFA) and 10% Owner in BLACKROCK NEW JERSEY INVESTMENT QUALITY MUNICIPAL TRUST INC ($RNJ) and 10% Owner in CADIZ INC ($CDZI) and 10% Owner in MFS HIGH INCOME MUNICIPAL TRUST ($CXE) and 10% Owner in MFS INVESTMENT GRADE MUNICIPAL TRUST ($CXH) and 10% Owner in CYPRESS BIOSCIENCE INC ($CYPB) and 10% Owner in NUVEEN CONNECTICUT PREMIUM INCOME MUNICIPAL FUND ($NTC) and 10% Owner in PACHOLDER HIGH YIELD FUND INC ($PHF) and 10% Owner in Voya PRIME RATE TRUST ($PPR) and 10% Owner in TRANSMONTAIGNE INC ($TMG) and 10% Owner in TEXAS INDUSTRIES INC ($TXI) and 10% Owner in TRUMP ENTERTAINMENT RESORTS, INC. ($NYSE: DJT) and 10% Owner in HOLLYWOOD MEDIA CORP ($HOLL) and in MORGAN STANLEY ($MS) and 10% Owner in MORGAN STANLEY ($MS) and Director in MORGAN STANLEY ($MS) and 10% Owner in GENELABS TECHNOLOGIES INC /CA ($GNLB) and 10% Owner in BLACKROCK MUNIYIELD QUALITY FUND, INC. ($MQY) and 10% Owner in REMEC LIQUIDATING TRUST ($REMC) and 10% Owner in Invesco Van Kampen Massachusetts Value Municipal Income Trust ($VMV) and 10% Owner in IMPSAT FIBER NETWORKS INC ($IMFN.OB) and 10% Owner in PRGX GLOBAL, INC. ($PRGX) and 10% Owner in VITAL IMAGES INC ($VTAL) and 10% Owner in EATON VANCE SENIOR INCOME TRUST ($EVF) and 10% Owner in NUVEEN CALIFORNIA DIVIDEND ADVANTAGE MUNICIPAL FUND ($NAC) and 10% Owner in LIME ENERGY CO. ($ELC) and in Feihe International Inc ($ADY) and 10% Owner in NUVEEN INSURED CALIFORNIA DIVIDEND ADVANTAGE MUNICIPAL FUND ($NKL) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and 10% Owner in BLACKROCK MUNICIPAL INCOME INVESTMENT TRUST ($BBF) and 10% Owner in PREMIUM STANDARD FARMS, INC. ($PORK) and 10% Owner in WCI COMMUNITIES INC ($WCI) and 10% Owner in CROSS COUNTRY HEALTHCARE INC ($CCRN) and 10% Owner in BLACKROCK MUNICIPAL BOND INVESTMENT TRUST ($BIE) and 10% Owner in PIONEER HIGH INCOME TRUST ($PHH) and 10% Owner in BLACKROCK NEW YORK MUNICIPAL INCOME TRUST II ($BFY) and 10% Owner in International Securities Exchange Holdings, Inc. ($ISE) and 10% Owner in BLACKROCK NEW YORK MUNICIPAL INCOME QUALITY TRUST ($BSE) and 10% Owner in DIGITALGLOBE, INC. ($DGI) and 10% Owner in EATON VANCE LTD DURATION INCOME FUND ($EVV) and 10% Owner in HAYES LEMMERZ INTERNATIONAL INC ($HAYZ) and 10% Owner in BLACKROCK MUNI NEW YORK INTERMEDIATE DURATION FUND, INC. ($MNE) and 10% Owner in DISTRIBUTED ENERGY SYSTEMS CORP ($DESC) and 10% Owner in VIATEL HOLDING BERMUDA LTD ($VTLAF) and in Gramercy Property Trust Inc. ($GPT) and 10% Owner in Gramercy Property Trust Inc. ($GPT) and 10% Owner in Intercontinental Exchange Holdings, Inc. ($ICE) and Director in TransMontaigne Partners L.P. ($TLP) and 10% Owner in ATS CORP ($FDSAW) and 10% Owner in Tower US Holdings Inc. ($AQR) and 10% Owner in China XD Plastics Co Ltd ($NBTE) and Director in China XD Plastics Co Ltd ($NBTE) and 10% Owner in Discover Financial Services ($DFS) and Director in Yongye International, Inc. ($YONG) and 10% Owner in Constant Contact, Inc. ($CTCT) and 10% Owner in MSCI Inc. ($MSCI) and 10% Owner in Nuveen Short Duration Credit Opportunities Fund ($JSD) and 10% Owner in Innocoll Holdings plc ($INNL) and 10% Owner in Leisure Acquisition Corp. ($LACQ) and 10% Owner in Bloom Energy Corp ($BE).
STANLEY MORGAN in Cyclacel Pharmaceuticals, Inc.
Trading Symbol: CYCCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STANLEY MORGAN: 10% Owner
Holdings: 2,276,852 shares
Latest Transaction: Nov 12 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STANLEY MORGAN in Cyclacel Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDSAW, RFA, MNE, BIE, BBF, MQY, RNJ, BSE, BFY, BE, CDZI, NBTE, CTCT, CCRN, CYCC, CYPB, DGI, DFS, DESC, EVV, EVF, ADY, GNLB, GPT, HAYZ, HOLL, IMFN.OB, INNL, ICE, ISE, VMV, LACQ, ELC, CXE, CXH, MS, MSCI, NAC, NTC, NKL, JSD, PHF, PHH, PORK, PRGX, REMC, TXI, AQR, TMG, TLP, NYSE: DJT, VTLAF, VTAL, PPR, WCI, YONG
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 12 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.80 | 328,850 | 263,080 | 2,276,852 | 2.6 M to 2.3 M (-12.62 %) |
Nov 10 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.86 | 47,050 | 40,463 | 2,605,702 | 2.7 M to 2.6 M (-1.77 %) |
Nov 10 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.86 | 24,100 | 20,726 | 2,652,752 | 2.7 M to 2.7 M (-0.90 %) |
Nov 06 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.88 | 103,172 | 90,791 | 2,676,852 | 2.8 M to 2.7 M (-3.71 %) |
Nov 04 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.87 | 4,300 | 3,741 | 2,780,024 | 2.8 M to 2.8 M (+0.15 %) |
Nov 04 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.87 | 4,300 | 3,741 | 2,775,724 | 2.8 M to 2.8 M (-0.15 %) |
Oct 05 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.90 | 57,200 | 51,480 | 2,780,024 | 2.8 M to 2.8 M (-2.02 %) |
Oct 05 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.90 | 57,200 | 51,480 | 2,837,224 | 2.8 M to 2.8 M (+2.06 %) |
Sep 03 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.87 | 7,200 | 6,264 | 2,780,024 | 2.8 M to 2.8 M (-0.26 %) |
Sep 03 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.87 | 7,200 | 6,264 | 2,787,224 | 2.8 M to 2.8 M (+0.26 %) |
Jul 06 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.15 | 7,400 | 8,510 | 2,780,024 | 2.8 M to 2.8 M (-0.27 %) |
Jul 06 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.15 | 7,400 | 8,510 | 2,787,424 | 2.8 M to 2.8 M (+0.27 %) |
May 05 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.61 | 3,200 | 1,952 | 2,780,024 | 2.8 M to 2.8 M (-0.11 %) |
May 05 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.61 | 3,200 | 1,952 | 2,783,224 | 2.8 M to 2.8 M (+0.12 %) |
Apr 02 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.36 | 53,900 | 19,404 | 2,780,024 | 2.8 M to 2.8 M (-1.90 %) |
Apr 02 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.36 | 53,900 | 19,404 | 2,833,924 | 2.8 M to 2.8 M (+1.94 %) |
Apr 02 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.32 | 81,520 | 26,086 | 2,780,024 | 2.9 M to 2.8 M (-2.85 %) |
Apr 02 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.35 | 19,800 | 6,930 | 2,861,544 | 2.9 M to 2.9 M (-0.69 %) |
Mar 31 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.35 | 43,580 | 15,253 | 2,881,344 | 2.9 M to 2.9 M (-1.49 %) |
Mar 31 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.39 | 19,600 | 7,644 | 2,924,924 | 2.9 M to 2.9 M (-0.67 %) |
Mar 27 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.40 | 28,400 | 11,360 | 2,944,524 | 3 M to 2.9 M (-0.96 %) |
Mar 27 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.40 | 18,900 | 7,560 | 2,972,924 | 3 M to 3 M (-0.63 %) |
Jan 06 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.42 | 60,300 | 25,326 | 2,991,824 | 3.1 M to 3 M (-1.98 %) |
Jan 06 2009 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.42 | 60,300 | 25,326 | 3,052,124 | 3 M to 3.1 M (+2.02 %) |
Dec 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.54 | 2,200 | 1,188 | 2,991,824 | 3 M to 3 M (-0.07 %) |
Dec 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.55 | 100 | 55 | 2,994,024 | 3 M to 3 M (0.00 %) |
Dec 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.54 | 2,200 | 1,188 | 2,993,924 | 3 M to 3 M (+0.07 %) |
Nov 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.50 | 3,600 | 1,800 | 2,991,724 | 3 M to 3 M (-0.12 %) |
Nov 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.46 | 5,500 | 2,530 | 2,995,324 | 3 M to 3 M (-0.18 %) |
Nov 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.46 | 5,500 | 2,530 | 3,000,824 | 3 M to 3 M (+0.18 %) |
Oct 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.03 | 100 | 103 | 2,995,324 | 3 M to 3 M (0.00 %) |
Oct 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.10 | 23,900 | 26,290 | 2,995,424 | 3 M to 3 M (-0.79 %) |
Oct 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.10 | 23,900 | 26,290 | 3,019,324 | 3 M to 3 M (+0.80 %) |
Sep 04 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.68 | 5,700 | 9,576 | 2,995,424 | 3 M to 3 M (+0.19 %) |
Sep 04 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.59 | 7,200 | 11,448 | 2,989,724 | 3 M to 3 M (-0.24 %) |
Sep 04 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.68 | 5,700 | 9,576 | 2,996,924 | 3 M to 3 M (-0.19 %) |
Aug 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.80 | 23,700 | 42,660 | 3,002,624 | 3 M to 3 M (-0.78 %) |
Aug 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.89 | 31,200 | 58,968 | 3,026,324 | 3 M to 3 M (+1.04 %) |
Aug 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.89 | 31,200 | 58,968 | 2,995,124 | 3 M to 3 M (-1.03 %) |
Jul 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.91 | 34,600 | 66,086 | 3,026,324 | 3.1 M to 3 M (-1.13 %) |
Jul 03 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.91 | 34,600 | 66,086 | 3,060,924 | 3 M to 3.1 M (+1.14 %) |
Jun 04 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 2.09 | 23,900 | 49,951 | 3,026,324 | 3.1 M to 3 M (-0.78 %) |
Jun 04 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.09 | 23,900 | 49,951 | 3,050,224 | 3 M to 3.1 M (+0.79 %) |
May 09 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 2.84 | 1,600 | 4,544 | 3,026,324 | 3 M to 3 M (-0.05 %) |
May 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 2.90 | 3,000 | 8,700 | 3,027,924 | 3 M to 3 M (-0.10 %) |
May 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.94 | 63,700 | 187,278 | 3,030,924 | 3 M to 3 M (+2.15 %) |
May 05 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 2.94 | 63,700 | 187,278 | 2,967,224 | 3 M to 3 M (-2.10 %) |
Mar 24 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 3.09 | 38,900 | 120,201 | 3,030,924 | 3.1 M to 3 M (-1.27 %) |
Mar 06 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 4.08 | 190,000 | 775,200 | 3,069,824 | 3.3 M to 3.1 M (-5.83 %) |
Mar 06 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 4.08 | 190,000 | 775,200 | 3,259,824 | 3.1 M to 3.3 M (+6.19 %) |
Mar 06 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 3.87 | 5,700 | 22,059 | 3,069,824 | 3.1 M to 3.1 M (-0.19 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Option Exercise | P | 8.44 | 168,750 | 1,424,250 | 168,750 | |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 5.50 | 50,000 | 275,000 | 3,075,524 | 3 M to 3.1 M (+1.65 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 5.47 | 23,380 | 127,889 | 3,025,524 | 3 M to 3 M (+0.78 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 4.80 | 350,000 | 1,680,000 | 3,002,144 | 2.7 M to 3 M (+13.20 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | S | 5.15 | 1,400 | 7,210 | 2,652,144 | 2.7 M to 2.7 M (+0.05 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 5.17 | 1,400 | 7,238 | 2,653,544 | 2.7 M to 2.7 M (-0.05 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 6.50 | 45,900 | 298,350 | 2,654,944 | 2.7 M to 2.7 M (-1.70 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | P | 6.50 | 45,900 | 298,350 | 2,700,844 | 2.7 M to 2.7 M (-1.67 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.89 | 120,900 | 953,901 | 2,654,944 | 2.5 M to 2.7 M (+4.77 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 12.00 | 100 | 1,200 | 2,534,044 | 2.5 M to 2.5 M (0.00 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.70 | 6,800 | 52,360 | 2,534,144 | 2.5 M to 2.5 M (+0.27 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.77 | 12,500 | 97,125 | 2,527,344 | 2.5 M to 2.5 M (+0.50 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.80 | 16,561 | 129,176 | 2,514,844 | 2.5 M to 2.5 M (+0.66 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.72 | 23,000 | 177,560 | 2,498,283 | 2.5 M to 2.5 M (+0.93 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.67 | 4,639 | 35,581 | 2,475,283 | 2.5 M to 2.5 M (+0.19 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.75 | 17,100 | 132,525 | 2,470,644 | 2.5 M to 2.5 M (+0.70 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 7.75 | 17,100 | 132,525 | 2,453,544 | 2.5 M to 2.5 M (-0.69 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.52 | 1,600 | 12,032 | 2,470,644 | 2.5 M to 2.5 M (+0.06 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.73 | 5,000 | 38,650 | 2,469,044 | 2.5 M to 2.5 M (+0.20 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.60 | 700 | 5,320 | 2,464,044 | 2.5 M to 2.5 M (+0.03 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.88 | 12,700 | 100,076 | 2,463,344 | 2.5 M to 2.5 M (+0.52 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.82 | 2,600 | 20,332 | 2,450,644 | 2.4 M to 2.5 M (+0.11 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 8.44 | 675,000 | 5,697,000 | 2,448,044 | 1.8 M to 2.4 M (+38.07 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.84 | 18,400 | 144,256 | 1,773,044 | 1.8 M to 1.8 M (+1.05 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 7.85 | 500 | 3,925 | 1,754,644 | 1.8 M to 1.8 M (-0.03 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 7.80 | 800 | 6,240 | 1,755,144 | 1.8 M to 1.8 M (+0.05 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 6.92 | 1,200 | 8,304 | 1,754,344 | 1.8 M to 1.8 M (+0.07 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Sell | S | 6.86 | 44,200 | 303,212 | 1,753,144 | 1.8 M to 1.8 M (-2.46 %) |
Feb 14 2008 | CYCC | Cyclacel Pharmaceu ... | MORGAN STANLEY | 10% Owner | Buy | P | 6.86 | 44,200 | 303,212 | 1,797,344 | 1.8 M to 1.8 M (+2.52 %) |
Page: 1